These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
511 related articles for article (PubMed ID: 37063862)
1. CD4+ conventional T cells-related genes signature is a prognostic indicator for ovarian cancer. Hua T; Liu DX; Zhang XC; Li ST; Yan P; Zhao Q; Chen SB Front Immunol; 2023; 14():1151109. PubMed ID: 37063862 [TBL] [Abstract][Full Text] [Related]
2. Establishment of an ovarian cancer exhausted CD8+T cells-related genes model by integrated analysis of scRNA-seq and bulk RNA-seq. Hua T; Liu DX; Zhang XC; Li ST; Wu JL; Zhao Q; Chen SB Eur J Med Res; 2024 Jul; 29(1):358. PubMed ID: 38970067 [TBL] [Abstract][Full Text] [Related]
3. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer. Song Y; Qu H BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619 [TBL] [Abstract][Full Text] [Related]
4. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq. Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614 [TBL] [Abstract][Full Text] [Related]
5. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis. Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402 [TBL] [Abstract][Full Text] [Related]
6. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer. Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K Front Immunol; 2022; 13():947802. PubMed ID: 36405735 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B Front Immunol; 2022; 13():931906. PubMed ID: 35958598 [TBL] [Abstract][Full Text] [Related]
8. Identifying the Role of Oxidative Stress-Related Genes as Prognostic Biomarkers and Predicting the Response of Immunotherapy and Chemotherapy in Ovarian Cancer. Liu Q; Yang X; Yin Y; Zhang H; Yin F; Guo P; Zhang X; Sun C; Li S; Han Y; Yang Z Oxid Med Cell Longev; 2022; 2022():6575534. PubMed ID: 36561981 [TBL] [Abstract][Full Text] [Related]
9. Machine learning-based model for CD4 Wang Z; Sun Z; Lv H; Wu W; Li H; Jiang T Sci Rep; 2024 Oct; 14(1):24426. PubMed ID: 39424871 [TBL] [Abstract][Full Text] [Related]
10. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets. Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873 [TBL] [Abstract][Full Text] [Related]
11. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X Front Immunol; 2022; 13():1056932. PubMed ID: 36479114 [TBL] [Abstract][Full Text] [Related]
12. Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer. Ding J; Wang C; Sun Y; Guo J; Liu S; Cheng Z Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830707 [TBL] [Abstract][Full Text] [Related]
13. Investigating PPT2's role in ovarian cancer prognosis and immunotherapy outcomes. Xu H; Zhang Y; Xie Z; Xie XF; Qiao WL; Wang M; Zhao BB; Hua T J Ovarian Res; 2024 Oct; 17(1):198. PubMed ID: 39394143 [TBL] [Abstract][Full Text] [Related]
14. Identification of CD4 Ning S; Wu J; Pan Y; Qiao K; Li L; Huang Q Front Immunol; 2022; 13():880769. PubMed ID: 35603183 [TBL] [Abstract][Full Text] [Related]
15. Construction and validation of a histone acetylation-related lncRNA prognosis signature for ovarian cancer. Hu XQ; Zhang XC; Li ST; Hua T Front Genet; 2022; 13():934246. PubMed ID: 36313424 [TBL] [Abstract][Full Text] [Related]
16. Immunogenic profiling of metastatic uveal melanoma discerns a potential signature related to prognosis. Wang J; Liu M; Sun J; Zhang Z J Cancer Res Clin Oncol; 2024 Jan; 150(1):23. PubMed ID: 38246894 [TBL] [Abstract][Full Text] [Related]
17. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer. Peng Y; Wang H; Huang Q; Wu J; Zhang M J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive profiling of endocrine metabolism identifies a novel signature with robust predictive value in ovarian cancer. Yu D; Luo Y; Guo R; Ma F; Chang Y; Dang J J Gene Med; 2024 May; 26(5):e3686. PubMed ID: 38689382 [TBL] [Abstract][Full Text] [Related]
19. Construction and validation of a transcription factors-based prognostic signature for ovarian cancer. Cheng Q; Li L; Yu M J Ovarian Res; 2022 Feb; 15(1):29. PubMed ID: 35227285 [TBL] [Abstract][Full Text] [Related]
20. Novel immune-related gene signature for risk stratification and prognosis prediction in ovarian cancer. Fei H; Han X; Wang Y; Li S J Ovarian Res; 2023 Oct; 16(1):205. PubMed ID: 37858138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]